Clinical trials showed Tirzepatide users lost 40% more weight than those using single-receptor GLP-1 agonists like Semaglutide
C.AlsharifI.MazzaR.LefrancB.et al (2018)
LL-37 is effective against a wide range of pathogens, including Staphylococcus aureus , Escherichia coli , Pseudomonas aeruginosa , Helicobacter pylori , and various fungi and enveloped viruses
For instance, phosphorylation of PPAR or the glucocorticoid receptor (GR) by Casein Kinase 2 or c-Jun N-terminal kinase (JNK) promotes nuclear export of the respective receptor 62,104,105
Kennedy AL, Morton JP, Manoharan I, Nelson DM, Jamieson NB, Pawlikowski JS et al
The FDA approval process isn't bureaucratic red tape, it's patient safety infrastructure